Literature DB >> 24664655

Rising antipsychotic prescriptions for children and youth: cross-sectoral solutions for a multimodal problem.

Nina Di Pietro1, Judy Illes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24664655      PMCID： PMC4049982          DOI： 10.1503/cmaj.131604

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Ten years of antipsychotic prescribing to children: a Canadian population-based study.

Authors:  Silvia Alessi-Severini; Robert G Biscontri; David M Collins; Jitender Sareen; Murray W Enns
Journal:  Can J Psychiatry       Date:  2012-01       Impact factor: 4.356

2.  First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.

Authors:  Constadina Panagiotopoulos; Rebecca Ronsley; Dean Elbe; Jana Davidson; Derryck H Smith
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-05

3.  National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

Authors:  Mark Olfson; Carlos Blanco; Linxu Liu; Carmen Moreno; Gonzalo Laje
Journal:  Arch Gen Psychiatry       Date:  2006-06

Review 4.  Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tamara Pringsheim; Darren Lam; Heidi Ching; Scott Patten
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

5.  Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth.

Authors:  Tamara Pringsheim; Constadina Panagiotopoulos; Jana Davidson; Josephine Ho
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-08

Review 6.  Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review.

Authors:  Tamara Pringsheim; Daniel Gorman
Journal:  Can J Psychiatry       Date:  2012-12       Impact factor: 4.356

7.  The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009.

Authors:  Tamara Pringsheim; Darren Lam; Scott B Patten
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-02       Impact factor: 2.576

8.  Drug research and treatment for children in Canada: A challenge.

Authors:  Michael J Rieder
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

9.  A three-country comparison of psychotropic medication prevalence in youth.

Authors:  Julie M Zito; Daniel J Safer; Lolkje T W de Jong-van den Berg; Katrin Janhsen; Joerg M Fegert; James F Gardner; Gerd Glaeske; Satish C Valluri
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-09-25       Impact factor: 3.033
  9 in total
  3 in total

Review 1.  The "Vulnerability" of Psychiatric Research Participants: Why This Research Ethics Concept Needs to Be Revisited.

Authors:  Dearbhail Bracken-Roche; Emily Bell; Eric Racine
Journal:  Can J Psychiatry       Date:  2016-04-05       Impact factor: 4.356

2.  Greater Arterial Stiffness in Children with or without Second-generation Antipsychotic Treatment for Mental Health Disorders: Rigidité Artérielle Plus Importante Chez Les Enfants Avec ou Sans Traitement Par Antipsychotiques de la Deuxième Génération Pour des Troubles de Santé Mentale.

Authors:  Amanda M Henderson; Nazrul Islam; George G S Sandor; Constadina Panagiotopoulos; Angela M Devlin
Journal:  Can J Psychiatry       Date:  2020-12-02       Impact factor: 4.356

Review 3.  Beyond Scientism and Skepticism: An Integrative Approach to Global Mental Health.

Authors:  Dan J Stein; Judy Illes
Journal:  Front Psychiatry       Date:  2015-11-23       Impact factor: 4.157
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.